There is compelling evidence, including low plasma levels of GSH [12, 13], and effective antioxidant therapies (both with GSH [14] and its precursor, N-acetylcysteine [14, 15]), of REDOX imbalance contributing to the pathophysiology of several brain conditions such as obsessive-compulsive disorder, schizophrenia, bipolar disorder, autism, trichotillomania, and neurodegenerative disorders (see refs
Geliefert wird Bergen Glutathion 300mg in einer lichtundurchlssigen, wiederverschliebaren Standdose
[DOI] [PubMed] [Google Scholar] Leung A, Chue P
A counteracting agent may be the stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419, an anti-ulcer peptide per-orally active (12-15) that may also affect many central disturbances (16-23), efficient in inflammatory bowel disease trials (PL 14736) (24, 25) and various wound treatment (26-28), no toxicity reported (12, 13, 24, 25)) which showed various hepatoprotective effects (29-31)